AzTrials
AzTrials

Drinking ExcessiveNCT05649982

Optimization of Guidance in a Digital Tool for Problematic Alcohol Use

A study testing ALVA in people with Drinking Excessive, run by Karolinska Institutet at 1 site in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the effects on alcohol consumption, and the consumption of time spent by a qualified clinician, by adding different forms of guidance to a digital intervention based on an alcohol diary and techniques from cognitive behavioral therapy and relapse prevention. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Drinking Excessive
What is being tested?
ALVA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteSweden
Study dates
11 Jan 2023to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 18 years of age
  • Access to internet
  • ≥8 points for men and ≥6 points for women on Alcohol Use Disorders Identification Test (AUDIT)

Who cannot join

  • Insufficient knowledge of the Swedish language
  • Difficulties reading or writing related to a digital intervention.
  • Other ongoing psychological treatment with a content similar to that in the current study (problematic alcohol use).
  • High suicide risk based on telephone assessment.
  • Other urgent need for more intensive psychiatric care, or addiction care services, based on telephone assessment.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Centre for Psychiatry Research

    Stockholm

Other trials in Sweden

About this study

The purpose of the study is to evaluate the effects on alcohol consumption, and the consumption of time spent by a qualified clinician, by adding different forms of guidance to a digital intervention based on an alcohol diary and techniques from cognitive behavioral therapy and relapse prevention. The participants will be adults with problematic alcohol use. The trial will be a 2*2 factorial experiment where written guidance and/or an extra mid-treatment telephone interview will be added to the basic digital intervention, by randomization. The randomized factorial experiment will create four equally large groups (1:1:1:1) who will receive different combinations of added guidance. Main outcome will be effects on alcohol consumption. Effects on alcohol consumption will also be combined with clinician time spent on guidance to assess the resource-effectiveness of added forms of guidance.

Being tested
ALVA

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ALVABehavioural

    Behavioural digital self-help intervention

Study groups in NCT05649982
Study groupRoleWhat they receive
Digital Tool for Problematic Alcohol UseExperimentalThis is the base version of the intervention with no added guidance.
Receives: Behavioral: ALVA
Digital Tool for Problematic Alcohol Use + Extra Telephone InterviewExperimentalThis is the same intervention as the base version, with an added mid-treatment telephone interview.
Receives: Behavioral: ALVA
Digital Tool for Problematic Alcohol Use + Written GuidanceExperimentalThis is the same intervention as the base version, with added weekly written guidance.
Receives: Behavioral: ALVA
Digital Tool for Problematic Alcohol Use + Extra Telephone Interview and Written GuidanceExperimentalThis is the same intervention as the base version, with added weekly written guidance and an added mid-treatment telephone interview.
Receives: Behavioral: ALVA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Standardized drinks per week (based on Time Line Follow Back)

    Changes in standardized drinks per week (using Time Line Follow Back)

    Measured: Immediately after the intervention

Secondary outcomes (9)
  1. Standardized drinks per week (based on Time Line Follow Back)

    Changes in standardized drinks per week (using Time Line Follow Back)

    Measured: 12 months after intervention

  2. Diagnostic criteria Alcohol Use Disorder

    Using SCID-5, number of diagnostic criteria 0-11, lower is better

    Measured: 6 months after intervention

  3. Credibility/Expectancy questionnaire

    Credibility/Expectancy questionnaire, score range 0-50, higher is better

    Measured: Mid-intervention (4 weeks after intervention start)

  4. Alcohol Use Disorders Identification Test

    Alcohol Use Disorders Identification Test (AUDIT), score range 0-40, lower is better

    Measured: 12 months after intervention

  5. Brunnsviken Brief Quality of Life Scale

    Brunnsviken Brief Quality of Life Scale (BBQ), score range 0-96, higher is better

    Measured: 12 months after intervention

  6. Penn Alcohol Craving Scale

    Penn Alcohol Craving Scale (PACS), score range 0-30, lower is better

    Measured: 12 months after intervention

  7. Patient Health Questionnaire 9

    Patient Health Questionnaire 9 (PHQ-9), score range 0-27, lower is better

    Measured: 12 months after intervention

  8. Generalized Anxiety Disorder 7

    Generalized Anxiety Disorder 7 (GAD-7), score range 0-21, lower is better

    Measured: 12 months after intervention

  9. Readiness to change questionnaire

    Readiness to change questionnaire (RCQ), determines if the participant are in a precontemplation phase, contemplation phase or action phase

    Measured: 12 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2022
  2. Study start11 Jan 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
2\*2 factorial experiment
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05649982
Sponsor's protocol ID
ALCOHOLDIARY2
Status last verified
Aug 2026
First submitted
6 Dec 2022
Last updated
24 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: IPD available anonymized on reasonable request.

Publications

  • Sundstrom C, Ivanova E, Lindner P, Johansson M, Kraepelien M. Investigating the added effects of guidance in digital psychological self-care for alcohol problems (ALVA)-protocol for a randomized factorial optimization trial. Trials. 2024 Feb 21;25(1):136. doi: 10.1186/s13063-024-07981-6.

    PubMed 38383426

Questions about this trial

What is this clinical trial studying?

A study testing ALVA in people with Drinking Excessive, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Standardized drinks per week (based on Time Line Follow Back) (time frame: Immediately after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05649982, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in